Article
Navitoclax mediates Interleukin-3 induced human umbilical vein endothelial cells survival and angiogenesis
2023-04-04
Abstract excerpt
Navitoclax is an effective pro-apoptotic agent against cancer cells. Uncontrolled cell survival is a hallmark of pathological angiogenesis in cancer and could promote plaque instability that contributes to atherosclerosis progression owing to intraplaque neovascularization. Cancer cell inhibition by navitoclax can restrain metastasis; therefore, it is possible to reduce endothelial cells survival and is expected t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9c41ea02-a574-5065-ab3a-74d295f94c54
- DOI
- 10.21203/rs.3.rs-2759691/v1
